Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7
- PMID: 15184139
- PMCID: PMC427753
- DOI: 10.1128/AEM.70.6.3417-3424.2004
Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7
Abstract
Escherichia coli O157:H7 is an endemic pathogen causing a variety of human diseases including mild diarrhea, hemorrhagic colitis, hemolytic-uremic syndrome, and thrombotic thrombocytopenic purpura. This study concerns the exploitation of bacteriophages as biocontrol agents to eliminate the pathogen E. coli O157:H7. Two distinct lytic phages (e11/2 and e4/1c) isolated against a human strain of E. coli O157:H7, a previously isolated lytic phage (pp01), and a cocktail of all three phages were evaluated for their ability to lyse the bacterium in vivo and in vitro. Phage e11/2, pp01, and the cocktail of all three virulent phages resulted in a 5-log-unit reduction of pathogen numbers in 1 h at 37 degrees C. However, bacteriophage-insensitive mutants (BIMs) emerged following the challenge. All tested BIMs had a growth rate which approximated that of the parental O157 strain, although many of these BIMs had a smaller, more coccoid cellular morphology. The frequency of BIM formation (10(-6) CFU) was similar for e11/2, pp01, and the phage cocktail, while BIMs insensitive to e4/1c occurred at the higher frequency (10(-4) CFU). In addition, BIMs commonly reverted to phage sensitivity within 50 generations. In an initial meat trial experiment, the phage cocktail completely eliminated E. coli O157:H7 from the beef meat surface in seven of nine cases. Given that the frequency of BIM formation is low (10(-6) CFU) for two of the phages, allied to the propensity of these mutants to revert to phage sensitivity, we expect that BIM formation should not hinder the use of these phages as biocontrol agents, particularly since low levels of the pathogen are typically encountered in the environment.
Figures



Similar articles
-
In vivo and ex vivo evaluations of bacteriophages e11/2 and e4/1c for use in the control of Escherichia coli O157:H7.Appl Environ Microbiol. 2010 Nov;76(21):7210-6. doi: 10.1128/AEM.01530-10. Epub 2010 Sep 17. Appl Environ Microbiol. 2010. PMID: 20851992 Free PMC article.
-
Assessment of Escherichia coli O157:H7-specific bacteriophages e11/2 and e4/1c in model broth and hide environments.Int J Food Microbiol. 2011 Jun 30;147(3):188-94. doi: 10.1016/j.ijfoodmicro.2011.04.001. Epub 2011 Apr 13. Int J Food Microbiol. 2011. PMID: 21531032
-
Meat Science and Muscle Biology Symposium: Development of bacteriophage treatments to reduce Escherichia coli O157:H7 contamination of beef products and produce.J Anim Sci. 2014 Apr;92(4):1366-77. doi: 10.2527/jas.2013-7272. Epub 2014 Feb 3. J Anim Sci. 2014. PMID: 24492574
-
Use of Bacteriophages to Control Escherichia coli O157:H7 in Domestic Ruminants, Meat Products, and Fruits and Vegetables.Foodborne Pathog Dis. 2017 Sep;14(9):483-493. doi: 10.1089/fpd.2016.2266. Epub 2017 Jun 21. Foodborne Pathog Dis. 2017. PMID: 28636835 Review.
-
A minireview on the in vitro and in vivo experiments with anti-Escherichia coli O157:H7 phages as potential biocontrol and phage therapy agents.Int J Food Microbiol. 2017 Feb 21;243:52-57. doi: 10.1016/j.ijfoodmicro.2016.12.004. Epub 2016 Dec 11. Int J Food Microbiol. 2017. PMID: 27978506 Review.
Cited by
-
Bacteriophages and phage-derived proteins--application approaches.Curr Med Chem. 2015;22(14):1757-73. doi: 10.2174/0929867322666150209152851. Curr Med Chem. 2015. PMID: 25666799 Free PMC article. Review.
-
The costs of evolving resistance in heterogeneous parasite environments.Proc Biol Sci. 2012 May 22;279(1735):1896-903. doi: 10.1098/rspb.2011.2259. Epub 2011 Dec 14. Proc Biol Sci. 2012. PMID: 22171085 Free PMC article.
-
Novel phage-based bio-processing of pathogenic Escherichia coli and its biofilms.World J Microbiol Biotechnol. 2012 Jan;28(1):47-60. doi: 10.1007/s11274-011-0791-6. Epub 2011 May 22. World J Microbiol Biotechnol. 2012. PMID: 22806779
-
Polyvalent Phage CoNShP-3 as a Natural Antimicrobial Agent Showing Lytic and Antibiofilm Activities against Antibiotic-Resistant Coagulase-Negative Staphylococci Strains.Foods. 2020 May 23;9(5):673. doi: 10.3390/foods9050673. Foods. 2020. PMID: 32456227 Free PMC article.
-
Bio-Control of Salmonella Enteritidis in Foods Using Bacteriophages.Viruses. 2015 Aug 24;7(8):4836-53. doi: 10.3390/v7082847. Viruses. 2015. PMID: 26305252 Free PMC article.
References
-
- Barrow, P. 2001. The use of bacteriophages for treatment and prevention of bacterial disease in animals and animal models of human infection. J. Chem. Technol. Biotechnol. 76:677-682.
-
- Berchieri, A., Jr., M. A. Lovell, and P. A. Barrow. 1991. The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res. Microbiol. 142:541-549. - PubMed
-
- Cagney, C., H. Crowley, G. Duffy, J. J. Sheridan, S. O’Brien, E. Carney, W. A. Anderson, D. A. McDowell, and I. S. Blair. 2004. Prevalence and numbers of Escherichia coli O157:H7 in minced beef and beef burgers from butcher shops and supermarkets in the Republic of Ireland. Food Microbiol. 21:203-212.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases